| Status : Published | Published On : Jul, 2026 | Report Code : VRHC1348 | Industry : Healthcare | Available Format :
|
Page : 146 |
The laser medical devices market size was estimated at about USD 7.85 billion in 2025 and is expected to reach around USD 8.56 billion in 2026, rising to roughly USD 18.94 billion by 2035, growing at approximately 9.2% CAGR from 2026 to 2035.
Research Highlights
Market growth is facilitated by increasing demand for minimally invasive procedures, continuous technological advancements in laser systems and growing prevalence of chronic and dermatological disorders along with expanding adoption of precision surgical technologies. Growing investments in healthcare infrastructure and medical innovation are further supporting market expansion across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The U.S. Food and Drug Administration (FDA) continues to approve advanced laser based medical technologies while the World Health Organization (WHO) supports initiatives for improved access to quality surgical care and medical technologies.
The industry is witnessing notable shifts in minimally invasive therapies, artificial intelligence-enabled imaging, and portable laser systems. One of the key trends shaping the market is the increasing adoption of precision laser technologies that improve treatment accuracy, reduce recovery time, and minimize tissue damage. Another emerging trend is the integration of digital imaging and robotic-assisted procedures, driven by technological innovation and growing demand for personalized healthcare.
The growth of the market is largely promoted by increasing demand for minimally invasive medical procedures and increasing prevalence of ophthalmic, cardiovascular, oncological, and dermatological conditions. Growing investments in hospitals, ambulatory surgical centers and specialty clinics are further accelerating market expansion. Additionally, continuous technological advancements in laser precision and treatment efficiency are boosting adoption across healthcare providers.
Despite favorable growth prospects, the market faces certain challenges that may limit expansion. High acquisition and maintenance costs of advanced laser systems continue to affect purchasing decisions particularly among smaller healthcare facilities. Furthermore, stringent regulatory approval processes and the requirement for skilled professionals increase operational complexity for manufacturers and healthcare providers.
The market presents significant opportunities in image guided laser therapies and next generation minimally invasive treatment technologies particularly driven by increasing demand for precision medicine and outpatient surgical procedures. Companies offering compact, energy efficient, and digitally integrated laser systems are well positioned to capture growing demand across hospitals and specialty clinics. Another key opportunity lies in artificial intelligence assisted laser applications, where investments in automation and smart healthcare technologies are improving clinical outcomes.
|
Report Metric |
Details |
|
Historical Period |
2020 - 2024 |
|
Base Year Considered |
2025 |
|
Forecast Period |
2026 - 2035 |
|
Market Size in 2025 |
USD 7.85 Billion |
|
Revenue Forecast in 2035 |
USD 18.94 Billion |
|
Growth Rate |
9.2% |
|
Segments Covered in the Report |
Product Type, Application, Technology, End User |
|
Report Scope |
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling |
|
Regions Covered in the Report |
North America, Europe, Asia Pacific, Rest of the World |
|
Key Companies |
Bausch + Lomb Corporation, BIOLASE, Inc., Candela Medical, Cutera, Inc., El.En. S.p.A., Fotona d.o.o., IRIDEX Corporation, Lumenis Ltd., Sisram Medical Ltd., TOPCON Corporation |
|
Customization |
Available upon request |
The diode laser systems segment accounted for the largest market share of approximately 39.8% in 2025 and is projected to expand at an estimated 9.0% CAGR through 2035 as strong adoption across dermatology, dentistry, ophthalmology, and cosmetic procedures continues to support segment leadership due to their compact design, high efficiency, and lower maintenance requirements.
The solid-state laser systems segment is expected to register the fastest growth at approximately 9.8% CAGR supported by increasing demand for precision surgical procedures and advanced oncology treatments.
Dermatology held the dominant position with an estimated 34.7% market share in 2025 reflecting increasing demand for aesthetic procedures, skin rejuvenation, scar treatment and hair removal therapies. Growing consumer preference for minimally invasive cosmetic procedures continues to strengthen market growth worldwide.
The oncology segment is projected to witness the fastest growth at approximately 9.9% CAGR due to expanding use of laser assisted tumor ablation and precision cancer therapies.
Pulsed laser systems represented approximately 46.2% of the market in 2025 supported by superior treatment precision, reduced thermal damage and wider application across medical specialties. Continuous technological advancements and growing preference for minimally invasive procedures continue to strengthen segment demand.
The ultrafast laser systems segment is expected to record the highest growth at approximately 10.1% CAGR owing to increasing demand for high precision microsurgery and advanced ophthalmic procedures.
Hospitals accounted for the largest market share of approximately 51.6% in 2025 supported by higher patient volumes, comprehensive surgical infrastructure, and increasing investments in advanced medical technologies.
Specialty clinics are expected to witness the fastest growth at an estimated 9.7% CAGR due to increasing outpatient procedures and rising demand for specialized cosmetic and ophthalmic treatments.
North America accounted for approximately 37.6% of the market in 2025 supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures and continuous technological innovation. The United States remains the regional growth engine owing to strong investments in medical technology and favorable reimbursement for several laser-based procedures. The U.S. Food and Drug Administration (FDA) continues to approve advanced laser systems for clinical applications, encouraging manufacturers to introduce innovative therapeutic solutions.
Europe represented approximately 24.3% of the global market in 2025 due to increasing adoption of laser assisted surgical procedures, expanding healthcare expenditure and growing demand for aesthetic treatments. Countries including Germany, France, Italy, and the United Kingdom continue investing in advanced medical technologies and hospital modernization. The European Commission supports innovation through healthcare research programs, while the European Medicines Agency (EMA) continues strengthening regulatory oversight for medical technologies.
Asia Pacific accounted for nearly 21.8% of the market in 2025 supported by expanding healthcare infrastructure, growing medical tourism, increasing disposable incomes and increasing awareness of minimally invasive treatments. China, Japan, South Korea and India continue witnessing substantial investment in hospitals, specialty clinics and advanced surgical technologies. The World Health Organization (WHO) supports healthcare capacity building across the region while national regulatory authorities continue encouraging medical technology adoption.
The Rest of the World, comprising Latin America and the Middle East & Africa, contributed approximately 16.3% of the global market in 2025 supported by improving healthcare infrastructure, increasing access to specialized medical treatments, and rising investment in advanced diagnostic and therapeutic technologies. Government initiatives to modernize healthcare systems and strengthen clinical capabilities continue encouraging adoption of laser based medical devices. The WHO supports healthcare development programs across emerging economies, creating favorable opportunities for long term market expansion.
The market is highly competitive with global manufacturers focusing on product innovation, precision engineering, strategic collaborations and geographic expansion to strengthen market presence. Companies continue investing in research and development, digital imaging technologies and minimally invasive treatment solutions to improve clinical outcomes. The U.S. Food and Drug Administration (FDA) continues supporting innovation through medical device approvals, while the World Health Organization (WHO) promotes broader access to safe and effective surgical technologies worldwide.
Bausch + Lomb Corporation focuses on ophthalmic laser technologies, supported by strong clinical expertise, global distribution capabilities, and continuous investment in vision care innovation.
Candela Medical operates in the premium aesthetic laser segment, emphasizing advanced dermatology platforms, treatment precision, and innovative energy based medical technologies.
El.En. S.p.A. leverages extensive laser engineering expertise, global manufacturing capabilities, and continuous research to strengthen its position across medical and surgical laser applications.
Fotona d.o.o. specializes in multifunctional medical laser systems, supported by technological innovation, precision engineering, and a broad portfolio serving multiple clinical specialties.
IRIDEX Corporation develops ophthalmic laser solutions, supported by advanced retinal treatment technologies, strong clinical partnerships, and continuous product innovation.
In January 2025, BIOLASE, Inc. introduced expanded clinical education initiatives to accelerate adoption of advanced dental laser technologies across North America. The program strengthened practitioner training and supported wider use of minimally invasive laser procedures.
In March 2025, Cutera, Inc. launched next generation aesthetic laser platforms featuring enhanced treatment precision and improved workflow efficiency. The development reinforced the company's focus on advanced dermatology and cosmetic laser solutions.
In June 2025, Lumenis Ltd. expanded its minimally invasive laser surgery portfolio with new technologies for urology and aesthetic medicine. The launch strengthened its position in precision laser based therapeutic applications.
In September 2025, Sisram Medical Ltd. enhanced its aesthetic medical device portfolio by introducing advanced laser technologies designed to improve treatment safety and clinical outcomes. The expansion supported growing global demand for noninvasive cosmetic procedures.
In February 2026, TOPCON Corporation introduced upgraded ophthalmic imaging solutions integrated with laser treatment technologies to improve diagnostic accuracy and clinical efficiency. The innovation strengthened comprehensive eye care and precision treatment capabilities.
Product Type Insight and Forecast 2026 - 2035
Application Insight and Forecast 2026 - 2035
Technology Insight and Forecast 2026 - 2035
End User Insight and Forecast 2026 - 2035
Global Laser Medical Devices Market by Region
1. Research Overview
1.1. The Report Offers
1.2. Market Coverage
1.2.1. By
Product Type
1.2.2. By
Application
1.2.3. By
Technology
1.2.4. By
End User
1.3. Research Phases
1.4. Limitations
1.5. Market Methodology
1.5.1. Data Sources
1.5.1.1.
Primary Research
1.5.1.2.
Secondary Research
1.5.2. Methodology
1.5.2.1.
Data Exploration
1.5.2.2.
Forecast Parameters
1.5.2.3.
Data Validation
1.5.2.4.
Assumptions
1.5.3. Study Period & Data Reporting Unit
2. Executive Summary
3. Industry Overview
3.1. Industry Dynamics
3.1.1. Market Growth Drivers
3.1.2. Market Restraints
3.1.3. Key Market Trends
3.1.4. Major Opportunities
3.2. Industry Ecosystem
3.2.1. Porter’s Five Forces Analysis
3.2.2. Recent Development Analysis
3.2.3. Value Chain Analysis
3.3. Competitive Insight
3.3.1. Competitive Position of Industry
Players
3.3.2. Market Attractive Analysis
3.3.3. Market Share Analysis
4. Global Market Estimate and Forecast
4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2035
5. Market Segmentation Estimate and Forecast
5.1. By Product Type
5.1.1. Solid State Laser Systems
5.1.1.1. Market Definition
5.1.1.2. Market Estimation and Forecast to 2035
5.1.2. Gas Laser Systems
5.1.2.1. Market Definition
5.1.2.2. Market Estimation and Forecast to 2035
5.1.3. Diode Laser Systems
5.1.3.1. Market Definition
5.1.3.2. Market Estimation and Forecast to 2035
5.1.4. Dye Laser Systems
5.1.4.1. Market Definition
5.1.4.2. Market Estimation and Forecast to 2035
5.2. By Application
5.2.1. Dermatology
5.2.1.1. Market Definition
5.2.1.2. Market Estimation and Forecast to 2035
5.2.2. Ophthalmology
5.2.2.1. Market Definition
5.2.2.2. Market Estimation and Forecast to 2035
5.2.3. Dentistry
5.2.3.1. Market Definition
5.2.3.2. Market Estimation and Forecast to 2035
5.2.4. Cardiovascular
5.2.4.1. Market Definition
5.2.4.2. Market Estimation and Forecast to 2035
5.2.5. Oncology
5.2.5.1. Market Definition
5.2.5.2. Market Estimation and Forecast to 2035
5.2.6. Gynecology
5.2.6.1. Market Definition
5.2.6.2. Market Estimation and Forecast to 2035
5.2.7. Urology
5.2.7.1. Market Definition
5.2.7.2. Market Estimation and Forecast to 2035
5.2.8. Others
5.2.8.1. Market Definition
5.2.8.2. Market Estimation and Forecast to 2035
5.3. By Technology
5.3.1. Continuous Wave Laser Systems
5.3.1.1. Market Definition
5.3.1.2. Market Estimation and Forecast to 2035
5.3.2. Pulsed Laser Systems
5.3.2.1. Market Definition
5.3.2.2. Market Estimation and Forecast to 2035
5.3.3. Ultrafast Laser Systems
5.3.3.1. Market Definition
5.3.3.2. Market Estimation and Forecast to 2035
5.4. By End User
5.4.1. Hospitals
5.4.1.1. Market Definition
5.4.1.2. Market Estimation and Forecast to 2035
5.4.2. Ambulatory Surgical Centers
5.4.2.1. Market Definition
5.4.2.2. Market Estimation and Forecast to 2035
5.4.3. Specialty Clinics
5.4.3.1. Market Definition
5.4.3.2. Market Estimation and Forecast to 2035
5.4.4. Others
5.4.4.1. Market Definition
5.4.4.2. Market Estimation and Forecast to 2035
6. North America Market Estimate and Forecast
6.1. By
Product Type
6.2. By
Application
6.3. By
Technology
6.4. By
End User
6.4.1.
U.S. Market Estimate and Forecast
6.4.2.
Canada Market Estimate and Forecast
6.4.3.
Mexico Market Estimate and Forecast
7. Europe Market Estimate and Forecast
7.1. By
Product Type
7.2. By
Application
7.3. By
Technology
7.4. By
End User
7.4.1.
Germany Market Estimate and Forecast
7.4.2.
France Market Estimate and Forecast
7.4.3.
U.K. Market Estimate and Forecast
7.4.4.
Italy Market Estimate and Forecast
7.4.5.
Spain Market Estimate and Forecast
7.4.6.
Russia Market Estimate and Forecast
7.4.7.
Rest of Europe Market Estimate and Forecast
8. Asia-Pacific (APAC) Market Estimate and Forecast
8.1. By
Product Type
8.2. By
Application
8.3. By
Technology
8.4. By
End User
8.4.1.
China Market Estimate and Forecast
8.4.2.
Japan Market Estimate and Forecast
8.4.3.
India Market Estimate and Forecast
8.4.4.
South Korea Market Estimate and Forecast
8.4.5.
Rest of Asia-Pacific Market Estimate and Forecast
9. Rest of the World (RoW) Market Estimate and Forecast
9.1. By
Product Type
9.2. By
Application
9.3. By
Technology
9.4. By
End User
9.4.1.
Brazil Market Estimate and Forecast
9.4.2.
Saudi Arabia Market Estimate and Forecast
9.4.3.
South Africa Market Estimate and Forecast
9.4.4.
U.A.E. Market Estimate and Forecast
9.4.5.
Other Countries Market Estimate and Forecast
10. Company Profiles
10.1.
Bausch + Lomb Corporation
10.1.1.
Snapshot
10.1.2.
Overview
10.1.3.
Offerings
10.1.4.
Financial
Insight
10.1.5.
Recent
Developments
10.2.
BIOLASE
10.2.1.
Snapshot
10.2.2.
Overview
10.2.3.
Offerings
10.2.4.
Financial
Insight
10.2.5.
Recent
Developments
10.3.
Inc.
10.3.1.
Snapshot
10.3.2.
Overview
10.3.3.
Offerings
10.3.4.
Financial
Insight
10.3.5.
Recent
Developments
10.4.
Candela Medical
10.4.1.
Snapshot
10.4.2.
Overview
10.4.3.
Offerings
10.4.4.
Financial
Insight
10.4.5.
Recent
Developments
10.5.
Cutera
10.5.1.
Snapshot
10.5.2.
Overview
10.5.3.
Offerings
10.5.4.
Financial
Insight
10.5.5.
Recent
Developments
10.6.
Inc.
10.6.1.
Snapshot
10.6.2.
Overview
10.6.3.
Offerings
10.6.4.
Financial
Insight
10.6.5.
Recent
Developments
10.7.
El.En. S.p.A.
10.7.1.
Snapshot
10.7.2.
Overview
10.7.3.
Offerings
10.7.4.
Financial
Insight
10.7.5.
Recent
Developments
10.8.
Fotona d.o.o.
10.8.1.
Snapshot
10.8.2.
Overview
10.8.3.
Offerings
10.8.4.
Financial
Insight
10.8.5.
Recent
Developments
10.9.
IRIDEX Corporation
10.9.1.
Snapshot
10.9.2.
Overview
10.9.3.
Offerings
10.9.4.
Financial
Insight
10.9.5.
Recent
Developments
10.10.
Lumenis Ltd.
10.10.1.
Snapshot
10.10.2.
Overview
10.10.3.
Offerings
10.10.4.
Financial
Insight
10.10.5.
Recent
Developments
10.11.
Sisram Medical Ltd.
10.11.1.
Snapshot
10.11.2.
Overview
10.11.3.
Offerings
10.11.4.
Financial
Insight
10.11.5.
Recent
Developments
10.12.
TOPCON Corporation
10.12.1.
Snapshot
10.12.2.
Overview
10.12.3.
Offerings
10.12.4.
Financial
Insight
10.12.5.
Recent
Developments
11. Appendix
11.1. Exchange Rates
11.2. Abbreviations
Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.
Purchase Options
Latest Report
Research Methodology
Connect With Our Sales Team
Laser Medical Devices Market